B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.71 USD 1.74% Market Closed
Market Cap: 950.3m USD
Have any thoughts about
Bioventus Inc?
Write Note

Intrinsic Value

The intrinsic value of one BVS stock under the Base Case scenario is 10.14 USD. Compared to the current market price of 11.71 USD, Bioventus Inc is Overvalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BVS Intrinsic Value
10.14 USD
Overvaluation 13%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Bioventus Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BVS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BVS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Bioventus Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Bioventus Inc

Provide an overview of the primary business activities
of Bioventus Inc.

What unique competitive advantages
does Bioventus Inc hold over its rivals?

What risks and challenges
does Bioventus Inc face in the near future?

Has there been any significant insider trading activity
in Bioventus Inc recently?

Summarize the latest earnings call
of Bioventus Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioventus Inc.

Provide P/S
for Bioventus Inc.

Provide P/E
for Bioventus Inc.

Provide P/OCF
for Bioventus Inc.

Provide P/FCFE
for Bioventus Inc.

Provide P/B
for Bioventus Inc.

Provide EV/S
for Bioventus Inc.

Provide EV/GP
for Bioventus Inc.

Provide EV/EBITDA
for Bioventus Inc.

Provide EV/EBIT
for Bioventus Inc.

Provide EV/OCF
for Bioventus Inc.

Provide EV/FCFF
for Bioventus Inc.

Provide EV/IC
for Bioventus Inc.

Show me price targets
for Bioventus Inc made by professional analysts.

What are the Revenue projections
for Bioventus Inc?

How accurate were the past Revenue estimates
for Bioventus Inc?

What are the Net Income projections
for Bioventus Inc?

How accurate were the past Net Income estimates
for Bioventus Inc?

What are the EPS projections
for Bioventus Inc?

How accurate were the past EPS estimates
for Bioventus Inc?

What are the EBIT projections
for Bioventus Inc?

How accurate were the past EBIT estimates
for Bioventus Inc?

Compare the revenue forecasts
for Bioventus Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioventus Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioventus Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioventus Inc compared to its peers.

Compare the P/E ratios
of Bioventus Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioventus Inc with its peers.

Analyze the financial leverage
of Bioventus Inc compared to its main competitors.

Show all profitability ratios
for Bioventus Inc.

Provide ROE
for Bioventus Inc.

Provide ROA
for Bioventus Inc.

Provide ROIC
for Bioventus Inc.

Provide ROCE
for Bioventus Inc.

Provide Gross Margin
for Bioventus Inc.

Provide Operating Margin
for Bioventus Inc.

Provide Net Margin
for Bioventus Inc.

Provide FCF Margin
for Bioventus Inc.

Show all solvency ratios
for Bioventus Inc.

Provide D/E Ratio
for Bioventus Inc.

Provide D/A Ratio
for Bioventus Inc.

Provide Interest Coverage Ratio
for Bioventus Inc.

Provide Altman Z-Score Ratio
for Bioventus Inc.

Provide Quick Ratio
for Bioventus Inc.

Provide Current Ratio
for Bioventus Inc.

Provide Cash Ratio
for Bioventus Inc.

What is the historical Revenue growth
over the last 5 years for Bioventus Inc?

What is the historical Net Income growth
over the last 5 years for Bioventus Inc?

What is the current Free Cash Flow
of Bioventus Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioventus Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bioventus Inc

Current Assets 298.7m
Cash & Short-Term Investments 43.1m
Receivables 121.9m
Other Current Assets 133.7m
Non-Current Assets 470.8m
Long-Term Investments 1.9m
PP&E 39.2m
Intangibles 422.3m
Other Non-Current Assets 7.4m
Current Liabilities 211.5m
Accounts Payable 16.8m
Accrued Liabilities 125.7m
Other Current Liabilities 69m
Non-Current Liabilities 409.3m
Long-Term Debt 345m
Other Non-Current Liabilities 64.2m
Efficiency

Earnings Waterfall
Bioventus Inc

Revenue
555.1m USD
Cost of Revenue
-183.2m USD
Gross Profit
371.9m USD
Operating Expenses
-355.6m USD
Operating Income
16.2m USD
Other Expenses
-55.7m USD
Net Income
-39.5m USD

Free Cash Flow Analysis
Bioventus Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BVS Profitability Score
Profitability Due Diligence

Bioventus Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
36/100
Profitability
Score

Bioventus Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

BVS Solvency Score
Solvency Due Diligence

Bioventus Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
High D/E
Positive Net Debt
38/100
Solvency
Score

Bioventus Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BVS Price Targets Summary
Bioventus Inc

Wall Street analysts forecast BVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVS is 14.96 USD with a low forecast of 12.12 USD and a high forecast of 17.85 USD.

Lowest
Price Target
12.12 USD
4% Upside
Average
Price Target
14.96 USD
28% Upside
Highest
Price Target
17.85 USD
52% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BVS?

Click here to dive deeper.

Dividends

Bioventus Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BVS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BVS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Bioventus Inc

Country

United States of America

Industry

Health Care

Market Cap

950m USD

Dividend Yield

0%

Description

Bioventus, Inc. global medical technology company which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. The company is headquartered in Durham, North Carolina and currently employs 1,200 full-time employees. The company went IPO on 2021-02-11. The firm is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.

Contact

NORTH CAROLINA
Durham
4721 Emperor Boulevard, Suite 100
+19194746700.0
www.bioventus.com

IPO

2021-02-11

Employees

1 200

Officers

Senior VP & CFO
Mr. Mark L. Singleton
Senior VP, General Counsel & Corporate Secretary
Mr. Anthony D'Adamio
President, CEO & Director
Mr. Robert E. Claypoole
Senior Vice President of Operations
Mr. Mike Crowe B.S., M.B.A.
Vice President of Investor Relations & Treasurer
Mr. David Crawford
Senior VP & Chief Compliance Officer
Ms. Katrina J. Church J.D.
Show More
Senior VP & Chief Human Resources Officer
Ms. Helen Leupold
Managing Director of China & Asia Pacific
Mr. Larry Chen
Show Less

See Also

Discover More
What is the Intrinsic Value of one BVS stock?

The intrinsic value of one BVS stock under the Base Case scenario is 10.14 USD.

Is BVS stock undervalued or overvalued?

Compared to the current market price of 11.71 USD, Bioventus Inc is Overvalued by 13%.

Back to Top